AADs

Related by string. AADD . AADS * * *

Related by context. Frequent words. (Click for all words.) 62 ethambutol 62 trimethoprim sulfamethoxazole 62 Dasatinib 62 advanced adenomas 61 indinavir 61 secondary hyperparathyroidism 61 rilonacept 60 Recombinant Human 60 voriconazole 60 mycophenolate mofetil 60 tigecycline 60 Erlotinib 60 amphotericin B 60 Irinotecan 60 corticosteroid therapy 59 Antifungal 59 Thrombin 59 poor metabolizers 59 trimethoprim 59 ximelagatran 59 Lenalidomide 59 coinfected 59 gastrointestinal stromal tumors GIST 58 pegylated interferon alpha 58 pancreatic NET 58 Single Dose 58 cytostatic 58 GISTs 58 angiotensin converting enzyme inhibitors 58 interferon alfa 58 fluvastatin 58 Diabetic Macular Edema 58 hypophosphatemia 58 Abacavir 58 colorectal carcinoma 57 NYHA Class II 57 bleomycin 57 hematologic toxicity 57 hepatitis B HBV 57 Initiate Phase 57 Combination therapy 57 HBeAg positive 56 Torisel 56 relapsing forms 56 5-FU/LV 56 daunorubicin 56 TNF blocker 56 sulfasalazine 56 imipenem 56 TNF antagonists 56 Daclizumab 56 Raltegravir 56 Amrubicin 56 Pivotal Phase III 56 Completes Enrollment 55 Streptococcus pyogenes 55 mRCC 55 Receives Orphan Drug Designation 55 systemic corticosteroids 55 Epivir 55 post herpetic neuralgia PHN 55 Octreotide 55 hepatocellular cancer 55 Cethromycin 55 colorectal cancer CRC 55 hereditary antithrombin deficiency 55 chlorambucil 55 osteoarthritis rheumatoid arthritis 55 AMN# [001] 54 Chlamydia pneumoniae 54 Estradiol 54 Presents Positive 54 chlorthalidone 54 TELINTRA 54 IBS C 54 fumarate 54 Drug Resistant 54 rheumatoid arthritis Crohn disease 54 Cutaneous 54 hypertensives 54 VALSTAR 54 Clevudine 54 Initiates Phase II 54 oropharyngeal candidiasis 54 TYGACIL 54 castrate resistant prostate cancer 54 hepatitis C HCV 54 Inactivation 53 S aureus 53 CMV infection 53 virologic failure 53 patients undergoing percutaneous 53 Lubiprostone 53 grade gliomas 53 aminoglycosides 53 alpha interferon 53 Oncaspar 53 Immunoglobulin 53 Clostridium difficile associated 53 Panzem R 53 Protease

Back to home page